The second generation drug-eluting stent Xience V performs well in patients having primary PCI for ST elevation myocardial infarction, and has a better safety profile than that of bare metal stents, according to results of the EXAMINATION (Evaluation of Xience-V stent in Acute Myocardial INfArcTION) trial.
The study was a randomised controlled trial with an "all-comers" design to evaluate the Xience V stent in the complex setting of STEMI and to provide data that may be applicable to the real world population...
.